CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Lonza Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 27, 2021High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell6
Jan 24, 2018Variant Immunoglobulins With Improved Manufacturability2

Top competitors of Lonza Biologics

List of top competitors of Lonza Biologics based on patent oppositions.